James Cody joined Vigene's GMP services division as a Business Development Manager in Nov. 2018. Dr. Cody's scientific background is in cancer gene therapy, having completed a Ph.D. in adenoviral vector engineering for oncolytic virotherapy and postdoctoral research on oncolytic HSV. He has a long-standing interest in gene therapy and is eager to assist Vigene's clients in making their innovative new therapies a clinical reality.